CMS to Further Review CAS Coverage in January
September 28, 2011—The Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) of the Centers for Medicare & Medicaid Services (CMS) will convene a meeting on January 25, 2012, for the panel to review available evidence on various clinical strategies for the management of carotid atherosclerosis. Treatments and technologies used in the management of carotid atherosclerosis include medical therapy, carotid endarterectomy, and carotid artery stenting (CAS).
The meeting will focus on the impact on patient health outcomes of these strategies for management of carotid atherosclerosis and prevention of stroke in both symptomatic and asymptomatic patients, as well as evaluate generalizability of the available evidence to patients of differing age, sex, and racial/ethnic backgrounds.
Medicare addresses coverage of CAS in section 20.7 of the national coverage determination (NCD) manual (Pub. 100-03) entitled Percutaneous Transluminal Angioplasty. Sections B2, B3, and B4 of the NCD address coverage of CAS. To access the NCD for percutaneous transluminal angioplasty on the CMS Web site, click here.
MEDCAC meetings are announced in the Federal Register and on the CMS Web site: www.cms.gov. All MEDCAC meeting materials will be available before the meeting on the CMS Medicare Coverage Database Web site.